International Journal of Nephrology · Published 2025-01-01 · DOI 10.1155/ijne/9980649
Conclusion: GC therapy may improve kidney outcomes in patients with biopsy-proven AIN, especially when initiated early. These results support the need for prospective studies to further evaluate its efficacy in AIN management.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →